Drug Pricing and Value in Oncology
1The Wharton School, University of Pennsylvania, Philadelphia, USA. danzon@wharton.upenn.edu.
Cancer drug prices are rising faster than inflation, with limited data for comparisons. The US significantly influences global cancer drug expenditures and often has the highest prices.
Area of Science:
- Oncology
- Health Economics
- Pharmaceutical Policy
Background:
- Originator cancer drug prices are increasing rapidly, outpacing general inflation.
- Existing data are insufficient for comprehensive comparisons between cancer and other specialty drugs.
- The United States represents a major market, accounting for 46% of global cancer drug spending.
Purpose of the Study:
- To review evidence on cancer drug pricing, price growth, and value.
- To analyze factors contributing to high and increasing cancer drug prices, with a focus on the US market.
Main Methods:
- Literature review of existing evidence on cancer drug prices and value.
- Analysis of factors influencing cancer drug pricing, concentrating on the US context.
Main Results:
- Evidence indicates significantly higher price growth for originator cancer drugs compared to general inflation.
- The US market is a key driver of global cancer drug expenditures and pricing trends.
- Data limitations hinder robust price comparisons across different specialty drug categories.
Conclusions:
- Cancer drug prices are escalating at a concerning rate.
- Understanding the drivers of these high prices, particularly in the US, is crucial for policy and patient access.
- Further research is needed to enable robust comparisons and inform pricing strategies.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
07:54Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
